Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity (Q37590335)

21 August 2017

1 reference

title

Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity (English)

1 reference

21 August 2017

Charani Ranasinghe

1

1 reference

21 August 2017

Ian A Ramshaw

series ordinal

2

1 reference

21 August 2017

publication date

1 September 2009

1 reference

Expert Review of Vaccines

21 August 2017

published in

1 reference

21 August 2017

volume

8

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

1171-1181

1 reference

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

21 August 2017

cites work

1 reference

Exposing the immunology of naked DNA vaccines.

21 January 2018

1 reference

The role of interleukin-6 in mucosal IgA antibody responses in vivo

21 January 2018

1 reference

Fowlpox virus host range restriction: gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells

21 January 2018

1 reference

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

21 January 2018

1 reference

A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation

21 January 2018

1 reference

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.

21 January 2018

1 reference

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

21 January 2018

1 reference

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag

21 January 2018

1 reference

Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.

21 January 2018

1 reference

EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone

21 January 2018

1 reference

A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1.

21 January 2018

1 reference

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

21 January 2018

1 reference

DNA vaccines: ready for prime time?

21 January 2018

1 reference

Electropermeabilization of skeletal muscle enhances gene transfer in vivo

21 January 2018

1 reference

DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants.

21 January 2018

1 reference

Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults.

21 January 2018

1 reference

Improving vaccines by targeting antigens to dendritic cells

21 January 2018

1 reference

Vaccination strategies for mucosal immune responses

21 January 2018

1 reference

The Role of Mucosal Immunity in Prevention of HIV Transmission

21 January 2018

1 reference

Mucosal HIV vaccines: where are we now?

21 January 2018

1 reference

Mucosal AIDS vaccines: current status and future directions

21 January 2018

1 reference

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

21 January 2018

1 reference

Emergence and kinetics of simian immunodeficiency virus-specific CD8(+) T cells in the intestines of macaques during primary infection

21 January 2018

1 reference

Should a new tuberculosis vaccine be administered intranasally?

21 January 2018

1 reference

Is intranasal vaccination a feasible solution for tuberculosis?

21 January 2018

1 reference

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

21 January 2018

1 reference

Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo

21 January 2018

1 reference

Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system

21 January 2018

1 reference

Gut-homing (alpha(4)beta(7)(+)) Th1 memory responses after inactivated poliovirus immunization in poliovirus orally pre-immunized donors

21 January 2018

1 reference

Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine.

21 January 2018

1 reference

Antigen-specific T cell responses: determination of their frequencies, homing properties, and effector functions in human whole blood.

21 January 2018

1 reference

Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination

21 January 2018

1 reference

Long lived multi-isotype anti-HIV antibody responses following a prime-double boost immunization strategy

21 January 2018

1 reference

Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein

21 January 2018

1 reference

Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes

21 January 2018

1 reference

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.

21 January 2018

1 reference

Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein

21 January 2018

1 reference

Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.

21 January 2018

1 reference

Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.

21 January 2018

1 reference

Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.

21 January 2018

1 reference

Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic

21 January 2018

1 reference

Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa

21 January 2018

1 reference

Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes.

21 January 2018

1 reference

DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors

21 January 2018

1 reference

Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity

21 January 2018

1 reference

Recombinant poxviruses as mucosal vaccine vectors

21 January 2018

1 reference

Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization

21 January 2018

1 reference

Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration

21 January 2018

1 reference

Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.

21 January 2018

1 reference

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.

21 January 2018

1 reference

Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediate

21 January 2018

1 reference

The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36

21 January 2018

1 reference

Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines

21 January 2018

1 reference

Vaccination with combination of Fit3L and RANTES in a DNA prime-protein boost regimen elicits strong cell-mediated immunity and antitumor effect.

21 January 2018

1 reference

CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals

21 January 2018

1 reference

4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.

21 January 2018

1 reference

Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.

21 January 2018

1 reference

Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge

21 January 2018

1 reference

Influence of IFNgamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy.

21 January 2018

1 reference

How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?

21 January 2018

1 reference

Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa

21 January 2018

1 reference

Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL

21 January 2018

1 reference

High-avidity CD8+ T cells: optimal soldiers in the war against viruses and tumors

21 January 2018

1 reference

Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection.

21 January 2018

1 reference

Enhancement of mucosal immune response against HIV-1 Gag by DNA immunization

21 January 2018

1 reference

Modulation of CD8+ T cell avidity by increasing the turnover of viral antigen during infection

21 January 2018

1 reference

Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population

21 January 2018

1 reference

Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidity

21 January 2018

1 reference

Profiling the CD8low phenotype, an alternative career choice for CD8 T cells during primary differentiation

21 January 2018

1 reference

Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Differential Functional Avidity of Dengue Virus-Specific T-Cell Clones for Variant Peptides Representing Heterologous and Previously Encountered Serotypes

21 January 2018

1 reference

A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L

21 January 2018

1 reference

Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f

21 January 2018

1 reference

SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques

21 January 2018

1 reference

Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFN? or IL-12

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.86

1 reference

21 August 2017

1 reference